¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"erythrocyte fragility"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® osmotic fragility ÇÑ±Û »ïÅõ¾ÐÃë¾à¼º
¼³¸í   
  ÀûÇ÷±¸¼¼Æ÷ÀÇ »ïÅõ¾Ð Æ¯¼º º¯È­¿¡ ´ëÇÑ ¹Î°¨¼º. ÀûÇ÷±¸°¡ Àú³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸ頼¼Æ÷¸·ÀÇ ´É·ÂÀ» ÃʰúÇÒ ¶§±îÁö ´Ù·®ÀÇ ¹°À» Èí¼öÇÏ¿© ºÎÇ®¾î¿Ã¶ó ÆÄ¿­Ç졒ʡí³óµµÀÇ ³ªÆ®·ý ¿ë¾×¿¡ ³ëÃâÇϸé ÀûÇ÷±¸ÀÇ ¼¼Æ÷³»¾×ÀÌ ºüÁ®³ª°¡ Å©±â°¡ ÁÙ¾îµé¸ç ÆÄ±«µÈ´Ù. ¿¹¿ÜÀû Ãë¾à¼ºÀ̳ª ÀúÇ×¼ºÀº Æ¯Á¤ º´ÀÇ Áø´ÜÀû ±âÁØÀÌ µÉ¼ö ÀÖ´Ù. Á¤»ó¼¼Æ÷´Â 0.39~0.45% ¼Ò±Ý¹° ¿ë¾×¿¡¼­ ¿ëÇ÷ÀÌ ½ÃÀ۵Ǹç, 37¡É(98.6¢µ)¿¡¼­ 0.30~0.33% ¼Ò±Ý ¿ë¾×¿¡ ÀûÇ÷±¸¸¦ ³ëÃâ½ÃŰ¸é ¿ëÇ÷Àº 24½Ã°£ À̳»¿¡ ¿Ï·áµÈ´Ù.
¿µ¹® ESR(Erythrocyte Sedimentation Rate) ÇÑ±Û ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ
¼³¸í   
  Ç÷¾×ÀÌ ÀÀ°íµÇ´Â °ÍÀ» ¹æÁöÇϴ Ç×ÀÀ°íÁ¦¸¦ ³ÖÀº Ç÷¾×À» Ä§°­¿ë À¯¸®°ü¿¡ ³Ö¾î °¡¸¸È÷ ¼¼¿ö µÎ¾úÀ» ¶§ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â ¼Óµµ¸¦ À̸£´Â ¸»ÀÌ´Ù. 1918³â ½º¿þµ§ÀÇ º´¸®ÇÐÀÚ ÆÄ·¹¿ì½ºÀǠâ¾È¿¡ ÀÇÇÑ °ÍÀÌ´Ù. ÃøÁ¤¹æ¹ýÀ¸·Î ¿©·¯ °¡Áö°¡ Àִµ¥, ±¹Á¦Ç¥ÁعýÀ¸·Î´Â 1973³â ¿þ½ºÅͱ׷»¹ýÀÇ 1½Ã°£¹ýÀÌ ¼±Á¤µÇ¾úÀ¸¸ç, 1977³â ±×°ÍÀ» °³Á¤ÇÏ¿© °¢±¹¿¡¼­ ¾²µµ·Ï ±ÇÀåÇϰí ÀÖ´Ù. 1½Ã°£ ÈĠħ°­¿ë À¯¸®°ü À§ÂÊÀÇ Ç÷Àå±âµÕÀÇ ³ôÀ̸¦ mm·Î Àоî, ±×°ÍÀ» ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ¸¸¾à Ç÷Àå°ú ÀûÇ÷±¸ÀÇ °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ °æ¿ì, ÀûÇ÷±¸ÀÇ ¹Ðµµ°¡ ±× ÀÌÇÏ¿¡¼­´Â ÀÏÁ¤ÇÏ´Ù°í ¿©°ÜÁö´Â °÷ÀÇ ´«±ÝÀ» Àоî ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ÃøÁ¤ ¶§ÀÇ ½Ç³»¿Âµµ´Â 18~25µµ·Î ÇÑ´Ù. ÀϹÝÀûÀ¸·Î À̺¸´Ù ¿Âµµ°¡ ³ôÀº °æ¿ì´Â Ç÷ħ¹ÝÀÀÀÌ ÃËÁøµÇ¸ç, ³·Àº °æ¿ì´Â ´Ê¾îÁø´Ù. Á¤»ó °ªÀº 2~10mm(³²ÀÚ), 3~15mm(¿©ÀÚ)À̸ç 15¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ, 50¼¼ ÀÌ»óÀÇ °í·ÉÀÚ¿¡¼­´Â ¾à°£ ³ô´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragility
    Ãë¾à¼º, ¿©¸²
  • fragility test
    Ãë¾à¼º°Ë»ç
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • osmotic fragility curve
    »ïÅõ¾ÐÃë¾à¼º°î¼±
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç
  • vascular fragility
    Ç÷°üÃë¾à¼º
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • dimorphic erythrocyte
    µÎÇüÅÂÀûÇ÷±¸, ÀÌ»ó¼ºÀûÇ÷±¸
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
  • erythrocyte indices
    ÀûÇ÷±¸Áö¼ö
  • erythrocyte sedimentation
    ÀûÇ÷±¸Ä§°­
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
  • fragmented erythrocyte
    Á¶°¢ÀûÇ÷±¸, ºÐ¿­ÀûÇ÷±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte
    ÀûÇ÷±¸
  • nucleated erythrocyte
    À¯ÇÙÀûÇ÷±¸
  • fragility
    ¿©¸²
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç, »ïÅõ¾Ð¿©¸²¼º°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • osmotic fragility curve
    »ïÅõ¾ÐÃë¾à°î¼±, »ïÅõ¾ÐÀúÇ×°î¼±
  • fragility
    ¿©¸²
  • osmotic fragility
    »ïÅõ¾ÐÃë¾à¼º
  • vascular fragility
    Ç÷°ü¿©¸²
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º°Ë»ç, »ïÅõ¾Ð¿©¸²¼º°Ë»ç
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • coated erythrocyte
    ÇǸ·ÀûÇ÷±¸
  • crenated erythrocyte
    Å鳯ÀûÇ÷±¸
  • dimorphic erythrocyte
    µÎ¸ð¾çÀûÇ÷±¸, ÀÌ»ó¼ºÀûÇ÷±¸
  • median erythrocyte diameter
    Á¤ÁßÀûÇ÷±¸Áö¸§
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
  • erythrocyte sedimentation
    ÀûÇ÷±¸Ä§Àü
  • erythrocyte stippling
    ÀûÇ÷±¸¹ÝÁ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragility of blood
    ÀûÇ÷±¸ÆÄ±«¼º.
  • fragility test
    Ãë¾à½ÃÇè ÀûÇ÷±¸ ÆÄ±«½ÃÇè .
  • hemorrhagic diathesis,vascular fragility
    Ç÷°üÃë¾à¼º
  • hereditary fragility of bone
    À¯Àü¼º °ñ Ãë¾àÁõ (¡­Íéöªå°ñø).
  • hereditary fragility of bone
    À¯Àü¼º °ñÃë¾àÁõ (¡­Íéöªå°ñø).
  • agglutination of erythrocyte
    ÀûÇ÷±¸ÀÀÁý
  • anisocytic erythrocyte
    ºÎµ¿¼¼Æ÷¼º ÀûÇ÷±¸
  • fragmented erythrocyte
    ºÐ¿­ÀûÇ÷±¸
  • free erythrocyte porphyrin
    À¯¸®ÀûÇ÷±¸Æ÷¸£ÇǸ°
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·<--¿Ü¸·>ÀûÇ÷±¸
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • hyperchromic erythrocyte
    °í»ö¼Ò¼º ÀûÇ÷±¸(¡­îåúìϹ).
  • hypochromic erythrocyte
    Àú»ö¼Ò¼º ÀûÇ÷±¸(¡­îåúìϹ).
  • hypochromic erythrocyte
    Àú»ö¼Ò¼º ÀûÇ÷±¸(?ËøÌ´Ë´).
  • immature erythrocyte
    ¹Ì¼÷ÀûÇ÷±¸.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • capillary fragility test
    ¸ð¼¼(Ç÷)°üÃë¾à¼º ½ÃÇè.
  • fragility of blood
    ÀûÇ÷±¸ÆÄ±«¼º.
  • fragility test
    Ãë¾à½ÃÇè ÀûÇ÷±¸ ÆÄ±«½ÃÇè .
  • hemorrhagic diathesis,vascular fragility
    Ç÷°üÃë¾à¼º
  • hereditary fragility of bone
    À¯Àü¼º °ñÃë¾àÁõ (¡­Íéöªå°ñø).
  • hereditary fragility of bone
    À¯Àü¼º °ñ Ãë¾àÁõ (¡­Íéöªå°ñø).
  • osmotic fragility
    »ïÅõÃë(¾à)¼º(Ë×̬?ËâËÛ) ÀûÇ÷±¸ÀÇ .
  • osmotic fragility
    »ïÅõÃë(¾à)¼º(ß¶÷âöªå°àõ) ÀûÇ÷±¸ÀÇ .
  • osmotic fragility
    »ïÅõÃë¾à¼º(ß¶÷âöªå°àõ)
  • osmotic fragility curve
    »ïÅõ¾ÐÀúÇ×°î¼±(?ËøÌ°Ë­ËÛ) ÀûÇ÷±¸ÀÇ .
  • osmotic fragility curve
    »ïÅõ¾ÐÀúÇ×°î¼±(¡­î½ù÷ÍØàÊ) ÀûÇ÷±¸ÀÇ .
  • osmotic fragility test
    »ïÅõ¾ÐÃë¾à¼º °Ë»ç (¡­öªå°àõËþÞÛ).
  • agglutination of erythrocyte
    ÀûÇ÷±¸ÀÀÁý
  • anisocytic erythrocyte
    ºÎµ¿¼¼Æ÷¼º ÀûÇ÷±¸
  • basophilic erythrocyte
    È£¿°±â¼º ÀûÇ÷±¸(?ËøÌ´Ë´).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Polychromatophilic erythrocyte
    ¹µ»öµëÀûÇ÷±¸
    [¿¾ ¿ë¾î] ´Ù¿°¼ºÀûÇ÷±¸
  • Stroma of erythrocyte
    ÀûÇ÷±¸¹öÆÀÁú
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÁöÁú
  • Plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÇüÁú¸·
  • Erythrocyte
    ÀûÇ÷±¸
    [¿¾ ¿ë¾î] ÀûÇ÷±¸
  • Erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
    [¿¾ ¿ë¾î] Ç÷¿µ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte ghost
    ÀûÇ÷±¸(îåúìϹ) ºó²®Áú
  • erythrocyte maturation factor
    ÀûÇ÷±¸ ¼º¼÷ ÀÎÀÚ (îåúìϹà÷âÙì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragility
    Ãë¾à¼º, ºÎ¼­Áö±â ½¬¿ò
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EA early antigen; educational age; egg albumin; electric affinity; electrical activity; electroacupunct...
FE fatty ester; fecal emesis; fetal erythroblastosis; fetal erythrocyte; fluid extract; fluorescent ery...
HCF [fetal] head-to-cervix force; heparin cofactor; hereditary capillary fragility; highest common facto...
MCF macrophage chemotactic factor; median cleft face; medium corpuscular fragility; microcomplement fixa...
OF occipitofrontal; open field [test]; optical fundus; orbitofrontal; osmotic fragility; osteitis fibro...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BFU-E Burst Forming Unit Erythrocyte
E Erythrocyte
EP Erythrocyte Protoporphyrin
EAP Erythrocyte acid phosphatase
EA Erythrocyte antibody
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • capillary fragility test
    ¸ð¼¼°ü Ãë¾à¼º ½ÃÇè, ¸ð¼¼Ç÷°ü Ãë¾à¼º ½ÃÇè
    Á¤¸Æ Ç÷·ù¸¸À» ÃæºÐÈ÷ Â÷´ÜÇÒ ¼ö ÀÖµµ·Ï Ç÷¾Ð´ë¸¦ 5ºÐ°£ °­ÇÏ°Ô Á¹¶ó¸Ç ÈÄ¿¡ ÀÌ·Î ÀÎÇÏ¿© »ý±ä ÇǺÎÀÇ Á¡ÃâÇ÷ÀÇ ¼ö¸¦ ¼¼¾î ¸ð¼¼°üÀÇ Ãë¾à¼ºÀ» °Ë»çÇÏ´Â °Í.
  • fragility
    Ãë¾à¼º, ºÎ¼­Áö±â ½¬¿ò
    ¿¬¼ÓÀ̳ª ÅëÇÕÀ» ºÐ¿­½ÃŰ´Â ¿øÀο¡ ´ëÇÏ¿© °¨¼ö¼ºÀÌ Àְųª ÀúÇ×¼ºÀÌ °á¿©µÇ¾î ÀÖ´Â °Í.
  • fragility test
    Ãë¾à ½ÃÇè
    ÀûÇ÷±¸ ÆÄ±« ½ÃÇè.
  • osmotic fragility test
    »ïÅõ¾Ð Ãë¾à¼º °Ë»ç
  • agglutination of erythrocyte
    ÀûÇ÷±¸ ÀÀÁý
  • dysmorphic erythrocyte
    ÀÌÇü ÀûÇ÷±¸
  • elevated erythrocyte sedimentation rate
    Áõ°¡µÈ ÀûÇ÷±¸ ħ°­ ¼Óµµ
  • erythrocyte
    ÀûÇ÷±¸
    Ç÷±¸ÀÇ ÇÑ °¡Áö. °ñ¼ö¿¡¼­ »ý»êµÇ¸ç »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â Çì¸ð±Û·ÎºóÀÌ ÀÖ´Ù. Ç÷»ö¼ÒÀÎ Çì¸ð±Û·Îºó ¶§¹®¿¡ ºÓ°Ô º¸ÀδÙ.
  • erythrocyte index
    ÀûÇ÷±¸ Áö¼ö
  • erythrocyte protoporphyrin test
    ÀûÇ÷±¸ ÇÁ·ÎÅäÆ÷¸£ÇǸ° ½ÃÇè
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸ ħ°­ ¼Óµµ
    ÀÀ°íµÇÁö ¾ÊÀº Ç÷¾×À» ´ãÀº °ü¿¡¼­ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â À²·Î¼­ ½Ã°£´ç mm·Î Ç¥½ÃÇÑ´Ù. ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡´Â ¿°ÁõÀÌ ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇϳª Ưº°ÇÑ Àå¾Ö¿¡ ´ëÇØ °íÀ¯ÇÏÁö´Â ¾Ê´Ù.
  • erythrocyte sedimentation test
    ÀûÇ÷±¸ ħ°­ ½ÃÇè
  • polychromatic erythrocyte
    ´Ù¿°¼º ÀûÇ÷±¸
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
capillary fragility The lack of resistance, or susceptibility, of capillaries to damage or disruption under conditions of increased stress.
(12 Dec 1998)
capillary fragility test A tourniquet test used to determine presence of vitamin C deficiency or thrombocytopenia; a circle 2.5 cm in diameter, the upper edge of which is 4 cm below the crease of the elbow, is drawn on the inner aspect of the forearm, pressure midway between the systolic and diastolic blood pressure is applied above the elbow for 15 minutes, and a count of petechiae within the circle is made: 10, normal; 10 to 20, marginal zone; over 20, abnormal.
See: Rumpel-Leede test.
Synonym: capillary resistance test, vitamin C test.
(05 Mar 2000)
osmotic fragility The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions.
(12 Dec 1998)
fragility Brittleness; liability to break, burst, or disintegrate.
Synonym: fragilitas.
Origin: L. Fragilitas
(05 Mar 2000)
fragility of the blood The susceptibility, or lack of resistance, of erythrocytes to haemolysis when exposed to increasingly hypotonic saline solutions.
(12 Dec 1998)
fragility test A test that measures the resistance of erythrocytes to haemolysis in hypotonic saline solutions; erythrocytes to be tested are added to varying concentrations of saline (usually ranging from 0.85 to 0.10% sodium chloride with 0.05% increments), and beginning and complete haemolysis are measured; normal erythrocytes show initial haemolysis at concentrations of 0.45 to 0.39% and complete haemolysis at 0.33 to 0.30%; in hereditary spherocytosis the fragility of the erythrocytes is markedly increased, whereas in thalassaemia, sickle cell anaemia, and obstructive jaundice the fragility of the erythrocytes is usually reduced.
Synonym: erythrocyte fragility test.
(05 Mar 2000)
rate, erythrocyte sedimentation A sedimentation rate, or sed rate , is a blood test that detects and is used to monitor inflammation activity. It is measured by recording the rate at which red blood cells (rbcs) sediment in a tube over time. It increases (the rbcs sediment faster) with more inflammation.
(12 Dec 1998)
erythrocyte A red blood cell.
(18 Nov 1997)
erythrocyte adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
erythrocyte aggregation Aggregation of erythrocytes probably resulting from changes in the negative surface charge (zeta potential) of the cells caused by the dielectric effect of proteins in the surrounding plasma, especially asymmetric macromolecules like fibrinogen and gamma-globulin.
(12 Dec 1998)
erythrocyte aggregation, intravascular The massing or clumping of erythrocytes in intact blood vessels in response to injury or in certain diseases, interfering with adequate blood flow. It is also called sludging of blood and intravascular agglutination.
(12 Dec 1998)
erythrocyte aging Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
(12 Dec 1998)
erythrocyte count A count of the number of red blood cells per unit volume in a sample of venous blood.
(12 Dec 1998)
erythrocyte deformability Ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature.
(12 Dec 1998)
erythrocyte ghost <cell biology> The membrane and cytoskeletal elements of the erythrocyte devoid of cytoplasmic contents, but preserving the original morphology.
(18 Nov 1997)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
erythrocyte fragility the susceptibility, or lack of resistance, of erythrocytes to hemolysis under certain circumstances; see mechanical f. and osmotic f.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
erythrocyte fragility Fragility of red blood cells.
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte
    ÀûÇ÷±¸
  • fragility
    ºÎ¼­Áö±â ½¬¿ò;¿©¸²;Çã¾à;Ç㹫ÇÔ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á